565 related articles for article (PubMed ID: 19614955)
1. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
2. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
3. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
[TBL] [Abstract][Full Text] [Related]
6. Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis.
Farkas G; Hofner P; Balog A; Takács T; Szabolcs A; Farkas G; Mándi Y
Eur Cytokine Netw; 2007 Mar; 18(1):31-7. PubMed ID: 17400536
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
[TBL] [Abstract][Full Text] [Related]
8. [TGF-Beta1-915G/C and TNF-alpha-308G/A polymorphisms in children with asthma].
Aytekin C; Doğu F; Ikincioğullari A; Eğin Y; Yüksek M; Bozdoğan G; Akar N; Babacan E
Tuberk Toraks; 2009; 57(1):62-7. PubMed ID: 19533439
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
10. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
[TBL] [Abstract][Full Text] [Related]
11. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
15. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
Pyrovolaki K; Mavroudi I; Papadantonakis N; Velegraki M; Ximeri M; Kalpadakis C; Gvazava G; Klaus M; Eliopoulos GD; Papadaki HA
Eur J Haematol; 2007 Dec; 79(6):531-8. PubMed ID: 17961177
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory and anti-inflammatory cytokine gene polymorphisms in hypersensitivity pneumonitis.
Kondoh K; Usui Y; Ohtani Y; Inase N; Miyake S; Yoshizawa Y
J Med Dent Sci; 2006 Mar; 53(1):75-83. PubMed ID: 16722148
[TBL] [Abstract][Full Text] [Related]
18. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
Beránek M; Kanková K; Benes P; Izakovicová-Hollá L; Znojil V; Hájek D; Vlková E; Vácha J
Am J Med Genet; 2002 May; 109(4):278-83. PubMed ID: 11992481
[TBL] [Abstract][Full Text] [Related]
20. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]